# Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout

> **NCT01129648** · PHASE2 · COMPLETED · sponsor: **BioCryst Pharmaceuticals** · enrollment: 87 (actual)

## Conditions studied

- Gout

## Interventions

- **DRUG:** Placebo
- **DRUG:** Allopurinol
- **DRUG:** Allopurinol
- **DRUG:** Allopurinol
- **DRUG:** BCX4208
- **DRUG:** Allopurinol
- **DRUG:** Allopurinol
- **DRUG:** Allopurinol
- **DRUG:** BCX4208
- **DRUG:** Allopurinol
- **DRUG:** Allopurinol
- **DRUG:** Allopurinol
- **DRUG:** BCX4208
- **DRUG:** Allopurinol
- **DRUG:** Allopurinol
- **DRUG:** Allopurinol
- **DRUG:** BCX4208

## Key facts

- **NCT ID:** NCT01129648
- **Lead sponsor:** BioCryst Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2012-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01129648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01129648, "Study to Evaluate sUA-Lowering Activity, Safety & PK Interaction of Oral BCX4208 & Allopurinol Admin. in Subjects w/Gout". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01129648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*